Skip to main content

previous disabled Page of 3
and
  1. Article

    Open Access

    European position paper on polypharmacy and fall-risk-increasing drugs recommendations in the World Guidelines for Falls Prevention and Management: implications and implementation

    The recent World Guidelines for Falls Prevention and Management provide several recommendations on how to prevent medication-related falls.

    Nathalie van der Velde, Lotta J. Seppala, Sirpa Hartikainen in European Geriatric Medicine (2023)

  2. Article

    Open Access

    Therapeutic dilemma’s: antipsychotics use for neuropsychiatric symptoms of dementia, delirium and insomnia and risk of falling in older adults, a clinical review

    This clinical review summarizes the current evidence on the risks of antipsychotic-related falls in older adults, including aspects of pharmacokinetics and -dynamics to assist clinicians in (de)prescribing ant...

    Netta Korkatti-Puoskari, Miia Tiihonen in European Geriatric Medicine (2023)

  3. Article

    Open Access

    Risk factors of pneumonia in persons with and without Alzheimer’s disease: a matched cohort study

    Pneumonia is a very common infection in the cognitively impaired adult population, often leading to long-term deterioration, in physical and cognitive performance. Evidence is lacking on whether chronic comorb...

    Heli Järvinen, Anna-Maija Tolppanen, Sirpa Hartikainen in BMC Geriatrics (2023)

  4. Article

    Open Access

    Recent hospitalization and risk of antidepressant initiation in people with Parkinson’s disease

    People with Parkinson’s disease (PD) are more likely to be hospitalized and initiate antidepressant use compared to people without PD. It is not known if hospitalization increases the risk of antidepressant in...

    Iida Hämäläinen, Miia Tiihonen, Sirpa Hartikainen, Anna-Maija Tolppanen in BMC Geriatrics (2022)

  5. Article

    Open Access

    Deprescribing practices, habits and attitudes of geriatricians and geriatricians-in-training across Europe: a large web-based survey

    To explore current deprescribing attitudes and practices among geriatricians and geriatricians-in-training across Europe.

    Eveline P. van Poelgeest, Lotta J. Seppala, Jihoo M. Lee in European Geriatric Medicine (2022)

  6. Article

    Open Access

    Statin discontinuation in persons with and without Alzheimer’s disease

    Although statin use is reported to decrease after dementia diagnosis, time to statin discontinuation and factors associated with discontinuation have not been studied in persons with Alzheimer’s disease (AD). ...

    Mai Vu, Raimo Kettunen, Anna-Maija Tolppanen in European Journal of Clinical Pharmacology (2022)

  7. Article

    Open Access

    Prevalence of oral anticoagulant use among people with and without Alzheimer’s disease

    Although cardio- and cerebrovascular diseases are common among people with Alzheimer’s disease (AD), it is unknown how the prevalence of oral anticoagulant (OAC) use changes in relation to AD diagnosis. We inv...

    Barkat Ali Babar, Mai Vu, Marjaana Koponen, Heidi Taipale in BMC Geriatrics (2022)

  8. Article

    Open Access

    Effect of individually tailored nutritional counselling on protein and energy intake among older people receiving home care at risk of or having malnutrition: a non-randomised intervention study

    With ageing, food intake may decrease and lead to an insufficient nutrient intake causing protein-energy malnutrition (PEM) which is associated with adverse health effects and increased mortality. The aim of t...

    Tarja Kaipainen, Sirpa Hartikainen, Miia Tiihonen, Irma Nykänen in BMC Geriatrics (2022)

  9. No Access

    Article

    Barriers and facilitators in using a Clinical Decision Support System for fall risk management for older people: a European survey

    The aim of our study was to assess barriers and facilitators to CDSS use reported by European physicians treating older fallers and explore differences in their perceptions.

    Kim J. Ploegmakers, Stephanie Medlock, Annemiek J. Linn in European Geriatric Medicine (2022)

  10. Article

    Open Access

    Automated multi-dose dispensing in persons with and without Alzheimer’s disease—impacts on pharmacotherapy

    We investigated the drug use before and after transition to automated multi-dose dispensing (MDD) service among persons with Alzheimer’s disease (AD) and compared whether the changes were similar in persons wi...

    Sanna Vallius, Heidi Taipale, Marjaana Koponen in European Journal of Clinical Pharmacology (2022)

  11. Article

    Open Access

    Opioids and Falls Risk in Older Adults: A Narrative Review

    Pain treatment is important in older adults but may result in adverse events such as falls. Opioids are effective for nociceptive pain but the evidence for neuropathic pain is weak. Nevertheless, both pain and...

    Roosa-Emilia Virnes, Miia Tiihonen, Niina Karttunen in Drugs & Aging (2022)

  12. Article

    Open Access

    Factors associated with daily opioid use among aged home care clients: a cross-sectional analysis of Resident Assessment Instrument data

    To examine which client characteristics and other factors, including possible adverse effects, identified in the Resident Assessment Instrument-Home Care (RAI-HC) are associated with daily opioid use among age...

    Heidi Mörttinen-Vallius, Sirpa Hartikainen, Heini Huhtala in European Geriatric Medicine (2022)

  13. Article

    Open Access

    Changes in the use of diabetes drugs among community-dwelling people with Alzheimer’s disease

    Type 2 diabetes is common in persons with Alzheimer’s disease (AD). Management of diabetes in persons with AD is challenging due to changing goals of care and susceptibility to adverse drug events including hy...

    Carlos López-Rubio, Marjaana Koponen, Pasi Lampela, Heidi Taipale in BMC Geriatrics (2021)

  14. Article

    Open Access

    The prevalence of and exact indications for daily opioid use among aged home care clients with and without dementia

    The increasing trend of opioid use for non-malignant pain among older people has raised concerns about whether opioids are used for appropriate indications. On the other hand, pain in patients with dementia ma...

    Heidi Mörttinen-Vallius, Sirpa Hartikainen in Aging Clinical and Experimental Research (2021)

  15. Article

    Open Access

    Incidence of antidepressant use among community dwellers with and without Parkinson’s disease – a nationwide cohort study

    Antidepressant use is more common in people with Parkinson’s disease (PD), but it is unknown when this difference emerges.

    Eerik Hentilä, Miia Tiihonen, Heidi Taipale, Sirpa Hartikainen in BMC Geriatrics (2021)

  16. Article

    Open Access

    The effect of comorbidities on survival in persons with Alzheimer’s disease: a matched cohort study

    Alzheimer’s disease (AD) is one of the leading causes of death world-wide, but little is known on the role of comorbidities on mortality among people with AD. We studied how comorbidities and age at AD diagnos...

    Blair Rajamaki, Sirpa Hartikainen, Anna-Maija Tolppanen in BMC Geriatrics (2021)

  17. Article

    Open Access

    Variation in groundwater manganese in Finland

    Increasing evidence has emerged that Mn derived from drinking water could be a health risk, especially for children. This study aimed to provide more information on the variation in Mn concentrations in well w...

    Anne Kousa, Hannu Komulainen, Tarja Hatakka in Environmental Geochemistry and Health (2021)

  18. Article

    Open Access

    Causes of death in a nationwide cohort of community-dwellers with Alzheimer’s disease

    Alzheimer’s disease (AD) is related to higher mortality but it is not entirely evident which causes of death explain this. The objective of this study was to assess the causes of death in a nationwide cohort o...

    Anna-Maija Tolppanen, Heidi Taipale, Marjaana Koponen, Jari Tiihonen in BMC Geriatrics (2020)

  19. Article

    Application of Healthcare ‘Big Data’ in CNS Drug Research: The Example of the Neurological and mental health Global Epidemiology Network (NeuroGEN)

    Neurological and psychiatric (mental health) disorders have a large impact on health burden globally. Cognitive disorders (including dementia) and stroke are leading causes of disability. Mental health disorde...

    Jenni Ilomäki, J. Simon Bell, Adrienne Y. L. Chan, Anna-Maija Tolppanen in CNS Drugs (2020)

  20. Article

    Open Access

    Length of hospital stay after hip fracture and readmission rates of persons with and without Alzheimer’s disease: a matched cohort study

    Hospital length of stays (LOS) for incident of hip fracture are decreasing, but it is unknown if these changes have negative impacts on vulnerable older patient populations, like those with Alzheimer’s disease...

    Blair Rajamaki, Marjaana Koponen, Sirpa Hartikainen, Anna-Maija Tolppanen in BMC Geriatrics (2020)

previous disabled Page of 3